Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist

Marta A S Perez1,2, Johanna Chiffelle1,3, Sara Bobisse1,3

  • 1Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.

Summary

TCRpcDist, a novel 3D approach, accurately clusters T-cell receptor repertoires by analyzing physico-chemical properties. This method aids in identifying antigen specificities for personalized cancer immunotherapies.